South Korea Suspends Sales Of Pfizer Antibiotic For Labeling Problems
This article was originally published in PharmAsia News
Executive Summary
South Korea's Ministry of Food and Drug Safety ordered Pfizer's Zithromax (azithromycin) antibiotic suspended from the market for three months on grounds the drug label contained inaccurate information.